Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis

被引:52
|
作者
Andersson, M. L. E.
Petersson, I. F.
Karlsson, K. E.
Jonsson, E. N.
Mansson, B.
Heinegard, D.
Saxne, T.
机构
[1] Spenshults Hosp Rheumat Dis, Halmstad, Sweden
[2] Lund Univ, Dept Rheumatol, Lund, Sweden
[3] Lund Univ, Sect Cell & Matrix Biol, Dept Expt Med Sci, Lund, Sweden
[4] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
D O I
10.1136/ard.2005.051292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To monitor changes in serum concentrations of cartilage oligomeric matrix protein (COMP) during a 24-h period to determine any diurnal variation, and to estimate the half life of COMP in the circulation in patients with symptomatic knee osteoarthritis and in those with rheumatoid arthritis. Methods: Serum samples were drawn every 4 h (7 samples/patient over 24 h) in 10 patients with knee osteoarthritis and 14 patients with rheumatoid arthritis. Osteoarthritis was defined radiographically and clinically (American College of Rheumatology (ACR) criteria) and rheumatoid arthritis according to the 1987 ACR criteria. Serum COMP was measured by sandwich ELISA. A statistical model for the diurnal variation in the COMP levels was developed using the computer program NONMEM. Results: No considerable changes in COMP levels were observed during the day between 08:00 and 21:00 in either group. A significant decrease in serum COMP was apparent during bed rest at night, reaching the lowest levels between 04:00 and 05:00 (p < 0.03 or better v all other time points) in patients with osteoarthritis and in those with rheumatoid arthritis. From the rate of decreasing serum COMP levels, a putative half life of COMP in the circulation was estimated to be 7.4 h. Conclusion: During normal daytime activities, serum COMP levels are constant. The decrease during the night indicates a rapid elimination of COMP once it has reached the circulation. The stable COMP levels during the day suggest that it is not necessary to further standardise the time of serum sampling in clinical practice.
引用
收藏
页码:1490 / 1494
页数:5
相关论文
共 50 条
  • [1] Diurnal variation in serum levels of cartilage oligomeric matrix protein (COMP) in individuals with rheumatoid arthritis
    Andersson, M. L. E.
    Petersson, I. F.
    Karlsson, K.
    Jonsson, N. E.
    Mansson, B.
    Heinegard, D.
    Saxne, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 143 - 143
  • [2] Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis
    M. Wisłowska
    B. Jabłońska
    [J]. Clinical Rheumatology, 2005, 24 : 278 - 284
  • [3] Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis
    Wislowska, M
    Jablonska, B
    [J]. CLINICAL RHEUMATOLOGY, 2005, 24 (03) : 278 - 284
  • [4] Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis
    El Defrawy, A. O.
    Gheita, T. A.
    Raslan, H. M.
    El Ansary, M. M.
    El Awar, A. H.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (09): : 917 - 923
  • [5] Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis and Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein
    Daniel Arellano, Ruben
    Sarai Aguilar, Lizette
    Arguello, Rafael
    Hernadez, Fernando
    Francisco Gonzalez, Faviel
    Moran, Javier
    [J]. ARCHIVES OF RHEUMATOLOGY, 2017, 32 (03) : 189 - 196
  • [6] Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis
    Vilím, V
    Olejárová, M
    Machácek, S
    Gatterová, J
    Kraus, VB
    Pavelka, K
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (09) : 707 - 713
  • [7] ROLE OF SERUM LEVELS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN DIAGNOSIS AND ASSESSMENT OF SEVERITY OF KNEE OSTEOARTHRITIS
    Shahi, U.
    Gupta, O. P.
    Ray, A.
    Mahdi, F.
    Bajpayi, J.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2012, 20 : S94 - S95
  • [8] SERUM LEVELS OF CARTILAGE OLIGOMERIC MATRIX PROTEIN AS A THERAPEUTIC INDICATOR FOR ONGOING TREATMENT OF KNEE OSTEOARTHRITIS
    Shahi, Utkarsh
    Shahi, Neha T.
    Mahdi, Farzana
    Ray, Amit
    Bajpayi, Jayant
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S100 - S101
  • [9] Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
    Maria LE Andersson
    Carina A Thorstensson
    Ewa M Roos
    Ingemar F Petersson
    Dick Heinegård
    Tore Saxne
    [J]. BMC Musculoskeletal Disorders, 7
  • [10] Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
    Andersson, Maria L. E.
    Thorstensson, Carina A.
    Roos, Ewa M.
    Petersson, Ingemar F.
    Heinegard, Dick
    Saxne, Tore
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2006, 7 (1)